The FDA has granted approval for the ANDA of Lupin’s Sacubitril and Valsartan Tablets for heart failure patients.
Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...
Experts warn that this early stage of heart failure, classified as Stage B, often goes unnoticed but can lead to severe ...
In the first 22 months of a mavacamten REMS program, few patients needed a temporary interruption in treatment for LVEF below 50%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback